Antikor Biopharma
PrivateLast Round
Grant
Nov 1, 2024
Total Funding Raised
$1.51M
Company Overview
Antikor Biopharma is a biotechnology company that specializes in the discovery and development of small-format Antibody Fragment Drug Conjugates (FDCs) for the treatment of solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Antikor Biopharma Comparables
Compare Antikor Biopharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Crescendo Biologics Ltd. | 75% | |
| Avacta Group | 70% | |
| Bicycle Therapeutics | 69% |
Antikor Biopharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 1, 2024 | ||||
| Grant | Apr 1, 2022 | ||||
| VC Round | Jul 31, 2019 |
Key People
Founding team and executive leadership
Antikor Biopharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Essex Bio-Technology | VC Round |
| Innovate UK | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 20, 2026
Monthly visitors increased 31% MoM.
- Apr 4, 2026
Monthly visitors increased 121% MoM.
Antikor Biopharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Antikor Biopharma's valuation, stock price, and market status.
Is Antikor Biopharma a public or private company?
Antikor Biopharma is a private company.
What is the current stock price of Antikor Biopharma?
Antikor Biopharma is a private company with no public stock price. No recent secondary market data is available.
How much is Antikor Biopharma worth (valuation)?
Valuation information for Antikor Biopharma is not publicly available.
Can I buy Antikor Biopharma stock?
Antikor Biopharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Antikor Biopharma's last funding round?
Antikor Biopharma's most recent funding round was Grant on November 1, 2024.
Who are the main investors in Antikor Biopharma?
Key investors in Antikor Biopharma include Essex Bio-Technology.
Will Antikor Biopharma IPO soon?
No public IPO plans have been announced for Antikor Biopharma.
How can I track Antikor Biopharma secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Antikor Biopharma's secondary market activity and sign up for updates.